Why Regeneron Pharmaceuticals (REGN) is Trending in 2025: Acquisition, Recovery, and Growth Signals
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has surged into the financial headlines with a string of impactful moves that mark a potential turning point for the biotech heavyweight. From strategic acquisitions…